Androgen receptor inhibitor treatments: Cardiovascular adverse events and comorbidity considerations in patients with non-metastatic prostate cancer.

Morgans AK, Shore N, Cope D, McNatty A, Moslehi J, Gomella L, Sartor O
Urol Oncol. 2021 39 (1): 52-62

PMID: 32958445 · DOI:10.1016/j.urolonc.2020.08.003

MeSH Terms (9)

Androgen Antagonists Cardiovascular Diseases Drug Interactions Humans Male Neoplasm Metastasis Prostatic Neoplasms, Castration-Resistant Risk Assessment Risk Factors

Connections (1)

This publication is referenced by other Labnodes entities:

Links